ROMA (ITALPRESS) – Diabetes today represents one of the main challenges of public health: a chronic condition with high impact that requires constant attention, structured care paths and tools that can support people in the daily management of pathology, while at the same time reducing the risk of complications and impact on the Health System. In Italy, more than 4.5 million people with diabetes are estimated and, according to the latest Annali AMD, the care is linked preponderantly to type 2 diabetes which represents about 90% of the people visited in the centers of Diabethology; about 30% of them are treated with insulin, alone or in association with other hypoglycemic drugs. Accu-Chek SmartGuide is the new modular, smart system, continuous glucose monitoring predictive (CGM) available now in Italy for people with diabetes. “The monitoring of glycemia is fundamental in the management of diabetes because it allows to know and customize the actions to be undertaken daily with the aim of maintaining glycemias close to normal values – explains Dario Pitocco, Associate Professor of Endocrinology at the Catholic University of the Sacred Heart, Director of Operational Unit of Diabetes Foundation of the University Polyclinic Augustine Gemini of Rome – The medical devices for the continuous monitoring of Glucose are used today These solutions help the person with diabetes manage everyday issues and promote a more proactive approach to support management and reduce the frequency of critical events. In particular, the latest generation systems have integrated predictive algorithms and AI based that can help to look beyond the instantaneous value of glucose, using for example the prediction function of the glucose trend in the next two hours.” According to Concetta Irace, Professor at the University of Magna Greece of Catanzaro, “it is not only the availability of real-time data to mark the progress of continuous monitoring of glucose (CGM), but the integration of CGM with artificial intelligence algorithms capable of interpreting data and anticipating what will happen. Today these technologies are not limited to showing glycemic values: they transform them into predictions, helping people with diabetes to manage therapy in a simpler and more conscious way. An important step forward, especially if one considers that hypoglycemia remains one of the main fears, especially during the night, when it is more difficult to recognize. Here artificial intelligence comes into play: some systems are already able to predict the risk of hypoglycemia, offering concrete support to improve the quality of life and make the management of the disease safer and more effective.” The new Accu-Chek SmartGuide system will be at the heart of a moment of confrontation, scheduled on 10 and 11 April at the nhow Hotel in Rome, dedicated to the medical-scientific community. The initiative will be an opportunity to explore the latest developments in continuous monitoring of glucose, the role of integrated predictive features and the digital ecosystem for the customization of treatment paths. “In Roche Diagnostics we have always placed people first, so we want to make more and more innovative solutions available that can transform people’s lives with diabetes, their caregiver and health professionals involved – concludes Burcak Celik, General Manager Roche Diagnostics Italy – to offer more flexibility and customization of the cura, supporting engagement and therapeutic adhesion in order to ensure an ever greater sustainability for the Health System”. -photo print office Roche –(ITALPRESS).
